De semillas a bioenergía: un camino de conversión para la valorización de semillas de ricino y jatrofa

The world’s energy matrix can be diversified with biodiesel from castor and jatropha oil. Hence, the objective of this study was to assess a conversion path for the valorization of castor and jatropha seeds. The results showed the maximum extraction of castor oil at 90 °C, 2 rpm, and 6 mm nozzle, achieving a yield of 36.97% and for jatropha oil at 100 °C, 1.5 rpm, and 10 mm nozzle, achieving a yield of 20.11%. The acid value and cloud point of castor and jatropha oil were 0.797 and 23.44 mg KOH/g, 10±1 °C and 12±0.55 °C, respectively; while the pour point was -3 °C for both. The acid value and cloud point for biodiesels ranged from 0.26-0.43 mg KOH/g, and -12.50-6.10 °C, respectively. The viscosity of oils and biodiesel ranged from 0.02-1.3 P. GC-MS indicated 66.38% of methyl ricinoleate in castor biodiesel and 31.64% of methyl oleate in jatropha biodiesel. The HHV for castor and jatropha biodiesel ranged from 32.37-40.25 MJ/kg.La matriz energética mundial puede diversificarse con biodiesel de ricino y de jatrofa. Por lo tanto, el objetivo de este trabajo fue evaluar la ruta de conversión de las semillas de ricino y jatrofa. Los resultados mostraron que la máxima extracción de aceite de ricino se dio a 90 °C, 2 rpm, y boquilla de 6 mm, alcanzando un rendimiento de 36,97% y para el aceite de jatrofa fue a 100 °C, 1,5 rpm, y boquilla de 10 mm, obteniendo un rendimiento de 20,11%. El índice de acidez y punto de nube del aceite de ricino y jatrofa fue de 0,797 y 23,44 mg de KOH/g, 10 ± 1 °C y 12 ± 0,55 °C, respectivamente, mientras que el punto de fluidez fue de -3 °C para ambos. El índice de acidez y el punto de nube del biodiésel de ricino y jatropha fueron 0,43 y 0,26 mg KOH/g, -12,50 °C y 6,10 °C, respectivamente. La viscosidad dinámica de los aceites y el biodiesel osciló entre 0,02 y 1,3 P. El análisis GC-MS indicó 66,38% de ricinoleato de metilo en biodiesel de higuerilla y 31,64% de oleato de metilo en biodiesel de jatrofa. El HHV para el biodiésel de ricino y jatrofa osciló entre 32,37 y 40,25 MJ/kg

New trends on the numerical representability of semiordered structures

[EN] We introduce a survey, including the historical back-ground, on different techniques that have recently been issued in the search for a characterization of the representability of semiordered structures, in the sense of Scott and Suppes, by means of a real-valued function and a strictly positive threshold of discrimination.This work has been supported by the research projects MTM2007-62499, ECO2008-01297, MTM2009-12872-C02-02 and MTM2010-17844 (Spain)Abrísqueta, F.; Campión, M.; Catalán, R.; De Miguel, J.; Estevan, A.; Induráin, E.; Zudaire, M.... (2012). New trends on the numerical representability of semiordered structures. Mathware & Soft Computing Magazine. 19(1):25-37. http://hdl.handle.net/10251/57632S253719

RICORS2040 : The need for collaborative research in chronic kidney disease

Chronic kidney disease (CKD) is a silent and poorly known killer. The current concept of CKD is relatively young and uptake by the public, physicians and health authorities is not widespread. Physicians still confuse CKD with chronic kidney insufficiency or failure. For the wider public and health authorities, CKD evokes kidney replacement therapy (KRT). In Spain, the prevalence of KRT is 0.13%. Thus health authorities may consider CKD a non-issue: very few persons eventually need KRT and, for those in whom kidneys fail, the problem is 'solved' by dialysis or kidney transplantation. However, KRT is the tip of the iceberg in the burden of CKD. The main burden of CKD is accelerated ageing and premature death. The cut-off points for kidney function and kidney damage indexes that define CKD also mark an increased risk for all-cause premature death. CKD is the most prevalent risk factor for lethal coronavirus disease 2019 (COVID-19) and the factor that most increases the risk of death in COVID-19, after old age. Men and women undergoing KRT still have an annual mortality that is 10- to 100-fold higher than similar-age peers, and life expectancy is shortened by ~40 years for young persons on dialysis and by 15 years for young persons with a functioning kidney graft. CKD is expected to become the fifth greatest global cause of death by 2040 and the second greatest cause of death in Spain before the end of the century, a time when one in four Spaniards will have CKD. However, by 2022, CKD will become the only top-15 global predicted cause of death that is not supported by a dedicated well-funded Centres for Biomedical Research (CIBER) network structure in Spain. Realizing the underestimation of the CKD burden of disease by health authorities, the Decade of the Kidney initiative for 2020-2030 was launched by the American Association of Kidney Patients and the European Kidney Health Alliance. Leading Spanish kidney researchers grouped in the kidney collaborative research network Red de Investigación Renal have now applied for the Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS) call for collaborative research in Spain with the support of the Spanish Society of Nephrology, Federación Nacional de Asociaciones para la Lucha Contra las Enfermedades del Riñón and ONT: RICORS2040 aims to prevent the dire predictions for the global 2040 burden of CKD from becoming true

New insights into the genetic etiology of Alzheimer's disease and related dementias

Characterization of the genetic landscape of Alzheimer's disease (AD) and related dementias (ADD) provides a unique opportunity for a better understanding of the associated pathophysiological processes. We performed a two-stage genome-wide association study totaling 111,326 clinically diagnosed/'proxy' AD cases and 677,663 controls. We found 75 risk loci, of which 42 were new at the time of analysis. Pathway enrichment analyses confirmed the involvement of amyloid/tau pathways and highlighted microglia implication. Gene prioritization in the new loci identified 31 genes that were suggestive of new genetically associated processes, including the tumor necrosis factor alpha pathway through the linear ubiquitin chain assembly complex. We also built a new genetic risk score associated with the risk of future AD/dementia or progression from mild cognitive impairment to AD/dementia. The improvement in prediction led to a 1.6- to 1.9-fold increase in AD risk from the lowest to the highest decile, in addition to effects of age and the APOE ε4 allele

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

Aplicación de la cianobacteria Spirulina sp. en la remoción y recuperación del colorante rojo congo de muestras acuosas.

En este trabajo se utilizó la biomasa de Cianobacteria Spirulina sp. en un sistema Bach, para remover el colorante ácido Rojo Congo (RC). Se estudió el efecto de variables de operación tales como dosis de biomasa. tiempo de contacto pH inicial y temperatura. Las mejores condiciones de operación para la remoción de Re fueron: dosis de biomasa de 1 gIL, pH 2, temperatura de 25 oC y tiempo de contacto de 2 horas. Los datos experimentales del equilibrio de biosorción se ajus1aron mejor al modelo de Langmuir y la cinética de adsorción siguió el modelo de pseudosegundo orden. La máxima capacidad de biosorción experimental de la biomasa fue de 418.70 mglg y eficiencia de recuperación del colorante fue superior a193%. Estos resultados sugieren que la biomasa de Spirulina sp., un adsorbente de bajo costo, presenta potencial para remover colorantes amónicos de efluentes industriales

Advanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-kB and nuclear factor of activated T cells pathways

BACKGROUND: The malignant mechanisms that control the development of cutaneous T-cell lymphoma (CTCL) are beginning to be identified. Recent evidence suggests that disturbances in specific intracellular signalling pathways, such as RAS-mitogen-activated protein kinase, T-cell receptor (TCR)-phospholipase C gamma 1 (PLCG1)-nuclear factor of activated T cells (NFAT) and Janus kinase (JAK)-signal transducer and activator of transcription (STAT), may play an essential role in the pathogenesis of CTCL. OBJECTIVES: To investigate the mechanisms controlling disease development and progression in mycosis fungoides (MF), the most common form of CTCL. METHODS: We collected 100 samples that were submitted for diagnosis of, or a second opinion regarding, MF between 2001 and 2018, 80% of which were in the early clinical stages of the disease. Formalin-fixed paraffin-embedded tissues were used for histological review and to measure the expression by immunohistochemistry of surrogate markers of activation of the TCR-PLCG1-NFAT, JAK-STAT and NF-?B pathways. Folliculotropism and large-cell transformation were also examined. RESULTS: NFAT and nuclear factor kappa B (NF-?B) markers showed a comparable activation status in early and advanced stages, while STAT3 activation was more frequent in advanced stages and was associated with large-cell transformation. Consistently with this observation, STAT3 activation occurred in parallel with MF progression in two initially MF-negative cases. A significant association of NFAT with NF-?B markers was also found, reflecting a common mechanism of activation in the two pathways. Genomic studies identified nine mutations in seven genes known to play a potential role in tumorigenesis in T-cell leukaemia/lymphoma, including PLCG1, JAK3 and STAT3, which underlies the activation of these key cell-survival pathways. A higher mutational allele frequency was detected in advanced stages. CONCLUSIONS: Our results show that STAT3 is activated in advanced cases and is associated with large-cell transformation, while the activation of NFAT and NF-?B is maintained throughout the disease. These findings could have important diagnostic and therapeutic implications. What's already known about this topic? Mycosis fungoides is characterized by a clonal expansion of T cells in the skin. The mechanisms controlling disease development and progression are not fully understood. What does this study add? An association of the nuclear factor of activated T cells and nuclear factor kappa B pathways was found, which could reflect a common mechanism of activation. These pathways were activated in early and advanced stages at the same level. Signal transducer and activator of transcription 3 activation was associated with large-cell transformation and was more frequent in advanced stages. A genomic analysis of cutaneous T-cell lymphoma-associated genes was performed. Nine mutations were detected. What is the translational message? These results could have important implications for the treatment of MF in the near future.Funding: This study has been supported by grants from the Instituto de Salud Carlos III, from the Ministerio de Economía, Industria y Competitividad (SAF2013-47416-R, CIBERONC-ISCIII, ISCIII-MINECO-AES-FEDER (Plan Estatal I + D + I 2013–2016): PI14/00221, PIE14/0064, PIE15/0081, PIE16/01294, and FIS 17/0957)), Asociación española contra el Cáncer (AECC), Comunidad Autónoma de Madrid and from the Instituto Formación e Investigación Hospital Universitario Marqués de Valdecilla (IDIVAL): NVAL16/18

Behcet's disease and genetic interactions between HLA-B*51 and variants in genes of autoinflammatory syndromes

Supplementary information:Rights and permissions.Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.Behcet's disease (BD) is an immune-mediated systemic disorder with a well-established genetic base. In a previous study, using a next generation sequencing approach, we found many rare variants and some functional polymorphisms in genes related to autoinflammatory syndromes (AID): CECR1, MEFV, MVK, NLRP3, NOD2, PSTPIP1 and TNFRSF1A in our BD cohort. Our strategy did not allow us to establish either number of patients with variants, proportion of individuals accumulating them or relationship with other genetic factors. With the goal to answer these questions, the individual samples were sequenced. Additionally, three functional polymorphisms: NLRP3 p.Gln703Lys, NOD2 p.Arg702Trp and p. Val955Ile were genotyped using TaqMan assays. A total of 98 patients (27.6%) carried at least one rare variant and 13 of them (3.7%) accumulated two or three. Functional regression model analysis suggests epistatic interaction between B51 and MEFV (P=0.003). A suggestive protective association of the minor allele of NOD2 p.Arg702Trp (P=0.01) was found in both, B51 positive and negative individuals. Therefore, a high percentage of patients with BD have rare variants in AID genes. Our results suggest that the association of MEFV with BD could be modulated by the HLA molecules; whereas the protective effect of NOD2 p.Arg702Trp would be independent of HLA.This work was supported by Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III (PI16/01373), Fondos FEDER and Plan Andaluz de Investigacion (CTS-0197).Peer reviewe